Middle East and Africa Intraoperative Radiation Therapy Market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.1% in the forecast period of 2021 to 2028 and is expected to reach USD 17.31 million by 2028. Increasing demand for Intraoperative radiation therapy in the medical industry is a major driver expected to boost growth of the Middle East and Africa Intraoperative radiation therapy market.

Intraoperative Radiotherapy (IORT) is a technique that involves delivery of a high dose of ionizing radiation to the tumor or tumor bed during surgery. It involves direct visualization of the tumor bed and spaces out normal tissues from the tumor bed that allows maximization of dose to the tumor while minimizing the dose to normal tissues. Thus, IORT is capable of delivering higher total effective dose to the tumor bed and facilitate dose escalation without significantly increasing normal tissue complications and improve therapeutic ratio.

Market Overview:

Because IORT radiation is targeted right at the tumor, the dose can be up to 2½ times higher than a safe dose of traditional radiation. This helps in keeping cancer from coming back in the same place. IORT has demonstrated its efficacy in a wide variety of tumors and cancers such as recurrent colorectal cancers, recurrent gynecological cancers and soft-tissue tumours. Recently, it has emerged as a popular treatment option for selected, early-stage breast cancer, owing to its ability to complete the entire course of radiotherapy during surgery.

View Report: https://www.databridgemarketresearch.com/reports/middle-east-and-af...

Factors driving the growth of the intraoperative radiation therapy market are increase in older population above 60 year, and advancement of modern sophisticated technology in IORT market such as artificial intelligence. On the other hand, risk associated with high dose radiation exposure such as skin problem and fatigue, and challenges associated with brand equity may restrain the market growth. Increasing research studies and clinical trials for safety and efficacy over the use of IORT in treating cancer and growing application of IORT in various cancer treatment such as breast cancer and brain tumor are opportunities in the market.

High competition among key players challenges the market growth acts as a challenge in the growth of market. I

This Middle East and Africa intraoperative radiation therapy market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Some of the major players operating in the intraoperative radiation therapy market are IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss MEDITECAG, Eckert & Ziegler. , Sensus Healthcare Inc, iCAD Inc., Elekta AB, SIT - S.I.T. Sordina IORT Technologies S.p.A., REMEDI Co., Ltd., GMV INNOVATING SOLUTIONS, Brainlab, AG and others.

Global intraoperative radiation therapy market is fragmented and major players have used various strategies such as collaboration, recognition, agreements, and others to increase their footprints in the intraoperative radiation therapy market.

For instance,

In April 2021, Varian Medical Systems, Inc. signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to fight global cancer burden. This will help the company to increase in access to care across regional and underserviced areas in Australia and Asia.
In October 2020, IntraOp Medical, Inc. and University of Verona in Italy announced the enrollment of the first patient in the PancFORT Trial. This helped the company to advance the science and clinical evidence supporting the role of IORT in treating this dreadful disease.

https://www.databridgemarketresearch.com/reports/asia-pacific-intra...
https://www.databridgemarketresearch.com/reports/middle-east-and-af...
https://www.databridgemarketresearch.com/reports/north-america-intr...

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- [email protected]